WORCESTER — UMass Chan Medical School has rescinded several dozen provisional acceptance offers for its PhD program in biomedical sciences, citing concerns over federal funding for medical research. The decision, announced on March 12, 2025, impacts students who were set to begin their doctoral studies in the fall.
According to UMass Chan, the move was necessary to ensure that current PhD students’ progress would not be disrupted by anticipated cuts to research funding. Additionally, the school stated that it wanted to avoid admitting new students who might face limited opportunities for dissertation research due to funding constraints.
“All impacted applicants are being offered the opportunity to receive priority consideration without the requirement to reapply, should they wish to join our PhD program in a future admissions cycle,” the school stated. However, current PhD candidates and applicants to UMass Chan’s T.H. Chan School of Medicine and Tan Chingfen Graduate School of Nursing are not affected.
UMass Chan is not alone in making such a decision. Several top universities across the country are reducing admissions or rescinding offers as they brace for funding challenges. Harvard University’s Graduate School of Arts and Sciences, for example, announced it would not admit any waitlisted students this year. The University of Pennsylvania has directed its department chairs to significantly reduce admission rates for graduate programs, and the University of California, San Diego has warned accepted students that their funding is not guaranteed.
Federal Policy Changes Driving Uncertainty
The cuts come in response to policy changes by the Trump administration, which has proposed significant reductions in funding from the National Institutes of Health (NIH), a primary source of grants for biomedical research. The administration’s budget plan seeks to reduce federal spending on academic research while shifting funding toward private-sector initiatives and defense-related biomedical projects.
Proponents of the funding cuts argue that the current system relies too heavily on taxpayer dollars to subsidize research that could be supported by private industry. They claim that reducing federal grants would encourage universities to seek alternative sources of funding, such as corporate partnerships, and increase competition for resources. Supporters also contend that academic research has become bloated with unnecessary expenditures and needs to be streamlined to focus on projects with clearer commercial or national security applications.
The proposed budget changes have sparked widespread concern among research institutions that rely on federal grants to sustain PhD programs and scientific advancements in fields such as cancer treatment, immunology, and neuroscience.
this is very wrong